Increasing evidence for the efficacy of hepatic arterial infusion chemotherapy combined with systemic therapy for advanced hepatocellular carcinoma with macrovascular invasion: tim...

por Moriya, Kei, Nagamatsu, Shinsaku, Uejima, Masakazu, Matsuo, Hideki
Publicado 2023

Embryonic stem cells reduce liver fibrosis in CCl(4)-treated mice

por Moriya, Kei, Yoshikawa, Masahide, Ouji, Yukiteru, Saito, Ko, Nishiofuku, Mariko, Matsuda, Ryosuke, Ishizaka, Shigeaki, Fukui, Hiroshi
Publicado 2008

Benefit of glucosyl Hesperidin in patients with primary biliary cholangitis: A multicenter, open-label, randomized control study

por Moriya, Kei, Asada, Kiyoshi, Suzuki, Shota, Enomoto, Masahide, Fujinaga, Yukihisa, Tsuji, Yuki, Namisaki, Tadashi, Yoshiji, Hitoshi
Publicado 2022

Liver Abscesses after Peritoneal Venous Shunt

por Kawaratani, Hideto, Tsujimoto, Tatsuhiro, Kubo, Takuya, Aihara, Yousuke, Takaya, Toshiaki, Uejima, Masakazu, Moriya, Kei, Noguchi, Ryuichi, Yoshiji, Hitoshi, Fukui, Hiroshi
Publicado 2013

The Effect of Inflammatory Cytokines in Alcoholic Liver Disease

por Kawaratani, Hideto, Tsujimoto, Tatsuhiro, Douhara, Akitoshi, Takaya, Hiroaki, Moriya, Kei, Namisaki, Tadashi, Noguchi, Ryuichi, Yoshiji, Hitoshi, Fujimoto, Masao, Fukui, Hiroshi
Publicado 2013

Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells

por Kitagawa, Koh, Moriya, Kei, Kaji, Kosuke, Saikawa, Soichiro, Sato, Shinya, Nishimura, Norihisa, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Publicado 2020

Efficacy of Serum Ferritin–Zinc Ratio for Predicting Advanced Liver Fibrosis in Patients with Autoimmune Hepatitis

por Moriya, Kei, Sato, Shinya, Nishimura, Norihisa, Kawaratani, Hideto, Takaya, Hiroaki, Kaji, Kosuke, Namisaki, Tadashi, Uejima, Masakazu, Nagamatsu, Shinsaku, Matsuo, Hideki, Yoshiji, Hitoshi
Publicado 2023

SARS-CoV-2 Vaccination Response in Japanese Patients with Autoimmune Hepatitis: Results of Propensity Score-Matched Case–Control Study

por Moriya, Kei, Nakakita, Tomoko, Nakayama, Natsuki, Matsuo, Yuya, Komeda, Yusuke, Hanatani, Junichi, Kaya, Daisuke, Nagamatsu, Shinsaku, Matsuo, Hideki, Uejima, Masakazu, Nakamura, Fumihiko
Publicado 2023

ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma

por Takaya, Hiroaki, Namisaki, Tadashi, Shimozato, Naotaka, Kaji, Kosuke, Kitade, Mitsuteru, Moriya, Kei, Sato, Shinya, Kawaratani, Hideto, Akahane, Takemi, Matsumoto, Masanori, Yoshiji, Hitoshi
Publicado 2019

Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis

por Ogawa, Hiroyuki, Kaji, Kosuke, Nishimura, Norihisa, Takagi, Hirotetsu, Ishida, Koji, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, Hitoshi
Publicado 2021

Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B

por Noguchi, Ryuichi, Kaji, Kosuke, Namisaki, Tadashi, Moriya, Kei, Kitade, Mitsuteru, Takeda, Kosuke, Kawaratani, Hideto, Okura, Yasushi, Aihara, Yosuke, Furukawa, Masanori, Mitoro, Akira, Yoshiji, Hitoshi
Publicado 2017

Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity

por Kaji, Kosuke, Takaya, Hiroaki, Saikawa, Soichiro, Furukawa, Masanori, Sato, Shinya, Kawaratani, Hideto, Kitade, Mitsuteru, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Publicado 2017

Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report

por Aihara, Yosuke, Moriya, Kei, Shimozato, Naotaka, Nagamatsu, Shinsaku, Kobayashi, Shinya, Uejima, Masakazu, Matsuo, Hideki, Ishida, Eiwa, Yagi, Hideo, Nakatani, Toshiya, Yoshiji, Hitoshi, Kikuchi, Eiryo
Publicado 2021

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects

por Takagi, Hirotetsu, Kaji, Kosuke, Nishimura, Norihisa, Ishida, Koji, Ogawa, Hiroyuki, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Mitoro, Akira, Yoshiji, Hitoshi
Publicado 2021

Dual therapy with zinc acetate and rifaximin prevents from ethanol-induced liver fibrosis by maintaining intestinal barrier integrity

por Fujimoto, Yuki, Kaji, Kosuke, Nishimura, Norihisa, Enomoto, Masahide, Murata, Koji, Takeda, Soichi, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, Hitoshi
Publicado 2021

Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepat...

por DOUHARA, AKITOSHI, MORIYA, KEI, YOSHIJI, HITOSHI, NOGUCHI, RYUICHI, NAMISAKI, TADASHI, KITADE, MITSUTERU, KAJI, KOSUKE, AIHARA, YOSUKE, NISHIMURA, NORIHISA, TAKEDA, KOSUKE, OKURA, YASUSHI, KAWARATANI, HIDETO, FUKUI, HIROSHI
Publicado 2015

Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model

por Nakanishi, Keisuke, Kaji, Kosuke, Kitade, Mitsuteru, Kubo, Takuya, Furukawa, Masanori, Saikawa, Soichiro, Shimozato, Naotaka, Sato, Shinya, Seki, Kenichiro, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Yoshiji, Hitoshi
Publicado 2019

TGR5 Activation Modulates an Inhibitory Effect on Liver Fibrosis Development Mediated by Anagliptin in Diabetic Rats

por Kaya, Daisuke, Kaji, Kosuke, Tsuji, Yuki, Yamashita, Satoko, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Moriya, Kei, Namisaki, Tadashi, Akahane, Takemi, Yoshiji, Hitoshi
Publicado 2019

Bile Acid Sequestrant, Sevelamer Ameliorates Hepatic Fibrosis with Reduced Overload of Endogenous Lipopolysaccharide in Experimental Nonalcoholic Steatohepatitis

por Tsuji, Yuki, Kaji, Kosuke, Kitade, Mitsuteru, Kaya, Daisuke, Kitagawa, Koh, Ozutsumi, Takahiro, Fujinaga, Yukihisa, Takaya, Hiroaki, Kawaratani, Hideto, Namisaki, Tadashi, Moriya, Kei, Akahane, Takemi, Yoshiji, Hitoshi
Publicado 2020

Novel oral plasminogen activator inhibitor-1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats

por Noguchi, Ryuichi, Kaji, Kosuke, Namisaki, Tadashi, Moriya, Kei, Kawaratani, Hideto, Kitade, Mitsuteru, Takaya, Hiroaki, Aihara, Yosuke, Douhara, Akitoshi, Asada, Kiyoshi, Nishimura, Norihisa, Miyata, Toshio, Yoshiji, Hitoshi
Publicado 2020